Mylan is a global pharmaceutical company known for producing generic and specialty medications. Founded in 1961, it has grown to become one of the largest generic drug manufacturers in the world. Mylan focuses on providing affordable healthcare options and has a diverse portfolio that includes treatments for various conditions, such as diabetes, asthma, and cardiovascular diseases. In 2020, Mylan merged with Upjohn, a division of Pfizer, to form a new company called Viatris. This merger aimed to enhance access to medicines and improve patient outcomes globally. Mylan's commitment to quality and affordability continues to play a significant role in the pharmaceutical industry.